Health Dictionary Find a Doctor

Conjunctivitis


Template:DiseaseDisorder infobox

For patient information click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sara Mehrsefat, M.D. [2]

Synonyms and keywords: Madras eye; Pink eye; Pinkeye; Inflammation of conjunctiva; Conjunctiva inflamed; Infective conjunctivitis; Acute Hemorrhagic Conjunctivitis; Hyperacute Bacterial Conjunctivitis (HBC); Koch-Weeks conjunctivitis

Overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [2]; Associate Editor(s)-in-Chief: Sara Mehrsefat, M.D. [3]

Overview

Conjunctivitis (con·junc·ti·vi·tis) is an inflammation of the conjunctiva (the outermost layer of the eye and the inner surface of the eyelids), most commonly due to an allergic reaction or an infection (usually bacterial or viral). Conjunctivitis may be classified based on the duration of symptoms into hyperacute, acute, or chronic. Additionally, based on the causality of the inflammation and age group, conjunctivitis may be classified into infective conjunctivitis (bacterial and viral), neonatal conjunctivitis (ophthalmia neonatorum), allergic conjunctivitis, keratoconjunctivitis sicca (dry eye syndrome), and superior limbic keratoconjunctivitis (SLK). Common causes of conjunctivitis include bacteria, viruses, and environmental factors. Viral conjunctivitis is the most common cause of infectious conjunctivitis both overall and in the adult population. Between 65% and 90% of cases of viral conjunctivitis are caused by adenoviruses. Bacterial conjunctivitis is the second most common cause. Allergic conjunctivitis is the most frequent cause, affecting 15% to 40% of the population. Noninfectious conjunctivitis includes keratoconjunctivitis sicca (dry eye syndrome) and superior limbic keratoconjunctivitis, which may caused by inflammation secondary to immune-mediated diseases. Prognosis for conjunctivitis usually good with treatment. Infective conjunctivitis resolves, in 65% of cases, within 2-5 days. Complete history will help determine the correct therapy. The symptoms of conjunctivitis differ based on the cause of the inflammation. Common symptoms to all forms of conjunctivitis include redness, excessive tearing, and irritation. Photophobia, itching, mucopurulent or non-purulent discharge, chemosis, burning eyes, blurred vision, and eyelid swelling are variable. Physical examination of patients with conjunctivitis is usually remarkable for conjunctival injections, epiphora, hyperemia, chemosis, and muco-purulent or watery discharge. However, ophthalmologic examination may be varies based on conjunctivitis subtypes. Laboratory tests are not often required in patients with mild conjunctivitis. Conjunctival cultures are generally reserved for conjunctivitis presenting with severe purulent discharge, and cases suspicious for gonococcal or chlamydial infection. Allergic conjunctivitis may be treated with artificial tears and topical antihistamines, vasoconstrictive agents, mast cell stabilizers, NSAIDs, and corticosteroids. Cool compresses are recommended to reduce eyelid and periorbital edema. Topical antimicrobial therapy is only recommended for patients with either bacterial or herpetic conjunctivitis, but not allergic or adenoviral conjunctivitis. Systemic antibiotic therapy is necessary to treat conjunctivitis due to Neisseria gonorrhoeae and Chlamydia trachomatis.

Historical Perspective

Conjunctivitis is an ancient disease. In 1750, neonatal conjunctivitis (ophthalmia neonatorum) was first described by S.T. Quellmaz. In 1883, Koch discovered the bacilli of two different forms of infectious conjunctivitis, or Egyptian ophthalmia.[1][2]

Classification

Conjunctivitis may be classified based on the duration of symptoms into hyperacute, acute, and chronic.[3][4] Additionally, conjunctivitis may be classified according to the causality of the inflammation or age groups into several subtypes: infective conjunctivitis (bacterial and viral), neonatal conjunctivitis (ophthalmia neonatorum), allergic conjunctivitis, keratoconjunctivitis sicca (dry eye syndrome), superior limbic keratoconjunctivitis, and chemical conjunctivitis.[5][6]

Pathophysiology

Conjunctivitis is defined as inflammation of bulbar and/or palpebral conjunctiva. Conjunctivitis has many etiologies, but the majority of cases can be caused by allergies or infection. Infective conjunctivitis is an infection of the conjunctiva either caused by viruses or bacteria. Airborne antigens may be involved in the pathogenesis of allergic conjunctivitis. Common airborne antigens include pollen, grass, and weeds. Keratoconjunctivitis sicca (dry eye syndrome) is a multifactorial disease and associated with different medical conditions.[7][8]

Causes

Common causes of conjunctivitis include bacteria, viruses, and environmental factors.[3] Viral conjunctivitis is the most common cause of infectious conjunctivitis both overall and in the adult population. Bacterial conjunctivitis is the second most common cause and is responsible for the majority of cases in children(Haemophilus influenzae,Moraxella catarrhalis,Streptococcus pneumoniae). Most of the cases in adults are caused by Staphylococcus aureus. Allergic conjunctivitis is the most frequent cause, affecting 15% to 40% of the population. Noninfectious conjunctivitis includes keratoconjunctivitis sicca (dry eye syndrome) and superior limbic keratoconjunctivitis caused by inflammation secondary to immune-mediated diseases or mechanical irritation.[7]

Differentiating Conjunctivitis from Other Diseases

Conjunctivitis symptoms and signs are relatively non-specific. Even after biomicroscopy, laboratory tests are often necessary to determine the underlying pathophysiology with certainty. An eye examination can help to differentiate conjunctivitis from other medical conditions.[9][10] Conjunctivitis must be differentiated from blepharitis, keratitis, and scleritis.

Epidemiology and Demographics

Conjunctivitis accounts for 1% of all primary care and emergency room visits. The incidence of viral conjunctivitis is approximately 80,000 per 100,000 cases with acute conjunctivitis. Viral conjunctivitis more commonly affects adults while bacterial conjunctivitis more commonly affects children. The prevalence of conjunctivitis varies according to the underlying cause, which may be influenced by the patient’s age, as well as the season of the year.[11]

Risk Factors

The most potent risk factor in the development of infective conjunctivitis is a direct or indirect contact with an infected person’s eye drainage. Common risk factors in the development of conjunctivitis are poor hygienic habits, contaminated personal articles, history of ocular diseases (dry eye, blepharitis, and anatomic abnormalities of the ocular surface), recent ocular surgery, medication use, and history of autoimmune disorders. Additionally, vaginal delivery is a risk factor for conjunctivitis in babies born to mothers infected with either Neisseria gonorrhoeae or Chlamydia trachomatis.[12][13]

Screening

General screening for conjunctivitis is not recommended. However, according to the Centers for Disease Control and Prevention (CDC), screening for sexually transmitted diseases (STDs) is recommended among pregnant women to prevent conjunctivitis and other medical conditions in newborns.[14]

Natural History, Complications, and Prognosis

If left untreated, viral conjunctivitis will generally clear without any complications. Bacterial conjunctivitis is often self-limited. If left untreated, bacterial conjunctivitis will clear within 1 or 2 weeks without any complications, and it is generally associated with a favorable long-term prognosis.[9] Allergic conjunctivitis improves by eliminating or significantly reducing contact with the allergen. If left untreated, most cases of allergic conjunctivitis may resolve without any long-term consequences. Keratoconjunctivitis sicca associated with Sjögren’s syndrome is associated with a particularly poor prognosis and requiring a longer course of treatment.[15][16][17] Prognosis for conjunctivitis is generally good with treatment.

Diagnosis

History and Symptoms

The symptoms of conjunctivitis differ based on the cause of the inflammation. Redness, excessive tearing, and irritation are symptoms common to all forms of conjunctivitis. Photophobia, itching, mucopurulent or non-purulent discharge, chemosis, burning eyes, blurred vision and eyelid swelling are variable. Complete history will help to determine whether the condition is associated with any specific environmental or work-related exposure.[15][9]

Physical Examination

Physical examination of patients with conjunctivitis is usually remarkable for conjunctival injections, epiphora, hyperemia, chemosis, and muco-purulent or watery discharge. However, ophthalmologic examination may be varies based on conjunctivitis subtypes.[18][7]

Laboratory Findings

Laboratory tests are not often required in patients with mild conjunctivitis. Conjunctival cultures are generally reserved for recurrent conjunctivitis, conjunctivitis recalcitrant to therapy, conjunctivitis presenting with severe mucopurulent discharge, and cases suspicious for gonococcal or chlamydial infection.[7][19]

Imaging Findings

There are no imaging findings associated with conjunctivitis. However, dynamic meibomian imaging (DMI) can be used to obtain a distinct picture of the entire everted inferior tarsal plate in a patient with keratoconjunctivitis sicca (dry eye syndrome).[20]

Other Diagnostic Studies

Other diagnostic studies for viral conjunctivitis include rapid antigen testing.[18] Other diagnostic studies for keratoconjunctivitis sicca (dry eye syndrome) conjunctivitis include corneal sensation, tear break up time, ocular surface staining, and Schirmer’s test.[21][22]

Treatment

Medical Therapy

Allergic conjunctivitis may be treated with artificial tears and topical antihistamines, vasoconstrictive agents, mast cell stabilizers, NSAIDs, and corticosteroids. Cool compresses are recommended to reduce eyelid and periorbital edema. Topical antimicrobial therapy is only recommended for patients with either bacterial or herpetic conjunctivitis, but not allergic or adenoviral conjunctivitis. Systemic antibiotic therapy is necessary to treat conjunctivitis due to Neisseria gonorrhoeae and Chlamydia trachomatis.

Surgery

Surgical intervention is not recommended for the management of infective and neonatal conjunctivitis. Allergic conjunctivitis is a self-limited disease, and extensive surgery may not be acceptable. However, surgical techniques include superficial keratectomy and penetrating keratoplasty are usually reserved for severe cases of corneal involvement. Despite the availability of efficient tear substitutes, many patients with keratoconjunctivitis sicca (dry eye syndrome) experience severe corneal injuries and a subsequent loss of vision. Surgical techniques include lateral tarsorrhaphy, punctal plugs, lens therapy, amniotic membrane transplantation, and salivary gland duct transposition.[19][1][23][24][25][26][27]

Primary Prevention

There are no formal established methods for primary prevention of allergic conjunctivitis, keratoconjunctivitis sicca (dry eye syndrome), and superior limbic keratoconjunctivitis. However, early determination of these conditions is very important in terms of morbidity.[28]

Secondary Prevention

Secondary prevention strategies following conjunctivitis include discontinued contact lens wear (infective conjunctivitis), ocular prophylaxis with 0.5% erythromycin ointment or 1% tetracycline hydrochloride (ophthalmia neonatorum), and avoiding the offending antigen (allergic conjunctivitis). Secondary prevention strategies following keratoconjunctivitis sicca (dry eye syndrome) include avoiding very dry environments, dusty areas, and prolonged visual tasks. There is no established method for secondary prevention of superior limbic keratoconjunctivitis (SLK). However, educating patients about disease process can improve compliance of patients with treatment, and help them to cope with the often prolonged symptoms.[15][28][29][30][27]

References

  1. 1.0 1.1 Mallika P, Asok T, Faisal H, Aziz S, Tan A, Intan G (2008). “Neonatal conjunctivitis – a review”. Malays Fam Physician. 3 (2): 77–81. PMC 4170304. PMID 25606121.
  2. Weeks JE (1996). “The bacillus of acute conjunctival catarrh, or ‘pink eye’. 1886”. Arch Ophthalmol. 114 (12): 1510–1. PMID 8953986.
  3. 3.0 3.1 National Eye Institute (2015). [1] Accessed on June 23, 2016
  4. Blochmichel E, Helleboid L, Corvec MP (1993). “Chronic allergic conjunctivitis”. Ocul Immunol Inflamm. 1 (1–2): 9–12. doi:10.3109/09273949309086529. PMID 22827184.
  5. Alfonso SA, Fawley JD, Alexa Lu X (2015). “Conjunctivitis”. Prim Care. 42 (3): 325–45. doi:10.1016/j.pop.2015.05.001. PMID 26319341.
  6. Leonardi A, Castegnaro A, Valerio AL, Lazzarini D (2015). “Epidemiology of allergic conjunctivitis: clinical appearance and treatment patterns in a population-based study”. Curr Opin Allergy Clin Immunol. 15 (5): 482–8. doi:10.1097/ACI.0000000000000204. PMID 26258920.
  7. 7.0 7.1 7.2 7.3 Azari AA, Barney NP (2013). “Conjunctivitis: a systematic review of diagnosis and treatment”. JAMA. 310 (16): 1721–9. doi:10.1001/jama.2013.280318. PMC 4049531. PMID 24150468.
  8. Kyei S, Koffuor GA, Ramkissoon P, Abokyi S, Owusu-Afriyie O, Wiredu EA (2015). “Possible Mechanism of Action of the Antiallergic Effect of an Aqueous Extract of Heliotropium indicum L. in Ovalbumin-Induced Allergic Conjunctivitis”. J Allergy (Cairo). 2015: 245370. doi:10.1155/2015/245370. PMC 4657065. PMID 26681960.
  9. 9.0 9.1 9.2 Leibowitz HM (2000). “The red eye”. N Engl J Med. 343 (5): 345–51. doi:10.1056/NEJM200008033430507. PMID 10922425.
  10. American Academy of ophthalmology (2016) http://eyewiki.aao.org/Bacterial_Conjunctivitis Accessed on June 27, 2016
  11. Høvding G (2008). “Acute bacterial conjunctivitis”. Acta Ophthalmol. 86 (1): 5–17. doi:10.1111/j.1600-0420.2007.01006.x. PMID 17970823.
  12. Epling J (2010). “Bacterial conjunctivitis”. BMJ Clin Evid. 2010. PMC 2907624. PMID 21718563.
  13. Cronau H, Kankanala RR, Mauger T (2010). “Diagnosis and management of red eye in primary care”. Am Fam Physician. 81 (2): 137–44. PMID 20082509.
  14. Centers for Disease Control and Prevention (2015) http://www.cdc.gov/std/tg2015/screening-recommendations.htm Accessed on June 29, 2016
  15. 15.0 15.1 15.2 Rose P (2007). “Management strategies for acute infective conjunctivitis in primary care: a systematic review”. Expert Opin Pharmacother. 8 (12): 1903–21. doi:10.1517/14656566.8.12.1903. PMID 17696792.
  16. Schaumberg DA, Dana R, Buring JE, Sullivan DA (2009). “Prevalence of dry eye disease among US men: estimates from the Physicians’ Health Studies”. Arch Ophthalmol. 127 (6): 763–8. doi:10.1001/archophthalmol.2009.103. PMC 2836718. PMID 19506195.
  17. Watson S, Tullo AB, Carley F (2002). “Treatment of superior limbic keratoconjunctivitis with a unilateral bandage contact lens”. Br J Ophthalmol. 86 (4): 485–6. PMC 1771108. PMID 11914237.
  18. 18.0 18.1 Jhanji V, Chan TC, Li EY, Agarwal K, Vajpayee RB (2015). “Adenoviral keratoconjunctivitis”. Surv Ophthalmol. 60 (5): 435–43. doi:10.1016/j.survophthal.2015.04.001. PMID 26077630.
  19. 19.0 19.1 Wood M (1999). “Conjunctivitis: diagnosis and management”. Community Eye Health. 12 (30): 19–20. PMC 1706007. PMID 17491982.
  20. Qazi Y, Aggarwal S, Hamrah P (2014). “Image-guided evaluation and monitoring of treatment response in patients with dry eye disease”. Graefes Arch Clin Exp Ophthalmol. 252 (6): 857–72. doi:10.1007/s00417-014-2618-2. PMC 4038672. PMID 24696045.
  21. Savini G, Prabhawasat P, Kojima T, Grueterich M, Espana E, Goto E (2008). “The challenge of dry eye diagnosis”. Clin Ophthalmol. 2 (1): 31–55. PMC 2698717. PMID 19668387.
  22. Beckman KA, Luchs J, Milner MS (2016). “Making the diagnosis of Sjögren’s syndrome in patients with dry eye”. Clin Ophthalmol. 10: 43–53. doi:10.2147/OPTH.S80043. PMC 4699514. PMID 26766898.
  23. Rajak S, Rajak J, Selva D (2015). “Performing a tarsorrhaphy”. Community Eye Health. 28 (89): 10–1. PMC 4579993. PMID 26435586.
  24. Baxter SA, Laibson PR (2004). “Punctal plugs in the management of dry eyes”. Ocul Surf. 2 (4): 255–65. PMID 17216100.
  25. Khodadoust A, Quinter AP (2003). “Microsurgical approach to the conjunctival flap”. Arch Ophthalmol. 121 (8): 1189–93. doi:10.1001/archopht.121.8.1189. PMID 12912699.
  26. Güerrissi JO, Belmonte J (2004). “Surgical treatment of dry eye syndrome: conjunctival graft of the minor salivary gland”. J Craniofac Surg. 15 (1): 6–10. PMID 14704553.
  27. 27.0 27.1 Nelson JD (1989). “Superior limbic keratoconjunctivitis (SLK)”. Eye (Lond). 3 ( Pt 2): 180–9. doi:10.1038/eye.1989.26. PMID 2695351.
  28. 28.0 28.1 Matejcek A, Goldman RD (2013). “Treatment and prevention of ophthalmia neonatorum”. Can Fam Physician. 59 (11): 1187–90. PMC 3828094. PMID 24235191.
  29. La Rosa M, Lionetti E, Reibaldi M, Russo A, Longo A, Leonardi S; et al. (2013). “Allergic conjunctivitis: a comprehensive review of the literature”. Ital J Pediatr. 39: 18. doi:10.1186/1824-7288-39-18. PMC 3640929. PMID 23497516.
  30. Messmer EM (2015). “The pathophysiology, diagnosis, and treatment of dry eye disease”. Dtsch Arztebl Int. 112 (5): 71–81, quiz 82. doi:10.3238/arztebl.2015.0071. PMC 4335585. PMID 25686388.


Template:WikiDoc Sources

Historical Perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Mehrsefat, M.D. [2]

Overview

Conjunctivitis is an ancient disease, and was first described by S.T. Quellmaz.[1] In 1881, Crédé introduced 2% silver nitrate for the first time as a prophylaxis treatment method for conjunctivitis in the newborns in Leipzig.[2]

Historical Perspective

  • In 1750, neonatal conjunctivitis (ophthalmia neonatorum) was first described by S.T. Quellmaz.[1]
  • In 1881, Crédé introduced 2% silver nitrate for the first time as a prophylaxis treatment method for conjunctivitis in the newborns in Leipzig.[2]
  • In 1883, Koch discovered the bacilli of two different forms of infectious conjunctivitis or Egyptian ophthalmia.
  • In 1886, Weeks discovered the same organism to be the cause of pink eye.[3]
  • In 1953, Micheal Hogan first described the association between atopic dermatitis and conjunctival inflammation.[4]
  • In 1963, Thygeson and Kimura first described superior limbic keratoconjunctivitis as a chronic, localized, filamentary conjunctivitis, and later this condition was given its name, superior limbic keratoconjunctivitis, by Theodore.[5]
  • In 1968, Tenzel and Corwin were the first to discover the association between thyroid abnormalities and development of superior limbic keratoconjunctivitis.[6]
  • In 1969, acute hemorrhagic conjunctivitis was first described as occurring in Ghana.[7]
  • Between 1981-2003, four major epidemics of acute hemorrhagic conjunctivitis had occurred in the Western Hemisphere.[8]
  • In 2006, an epidemic acute hemorrhagic conjunctivitis (involving more than 200,000 people) was reported as occurring in Brazil.[9]

References

  1. 1.0 1.1 Mallika P, Asok T, Faisal H, Aziz S, Tan A, Intan G (2008). “Neonatal conjunctivitis – a review”. Malays Fam Physician. 3 (2): 77–81. PMC 4170304. PMID 25606121.
  2. 2.0 2.1 “Reports from the obstetrical clinic in Leipzig. Prevention of eye inflammation in the newborn”. Am J Dis Child. 121 (1): 3–4. 1971. PMID 5543850.
  3. Weeks JE (1996). “The bacillus of acute conjunctival catarrh, or ‘pink eye’. 1886”. Arch Ophthalmol. 114 (12): 1510–1. PMID 8953986.
  4. HOGAN MJ (1952). “Atopic keratoconjunctivitis”. Trans Am Ophthalmol Soc. 50: 265–81. PMC 1313175. PMID 13102561.
  5. Watson S, Tullo AB, Carley F (2002). “Treatment of superior limbic keratoconjunctivitis with a unilateral bandage contact lens”. Br J Ophthalmol. 86 (4): 485–6. PMC 1771108. PMID 11914237.
  6. Nelson JD (1989). “Superior limbic keratoconjunctivitis (SLK)”. Eye (Lond). 3 ( Pt 2): 180–9. doi:10.1038/eye.1989.26. PMID 2695351.
  7. Azari AA, Barney NP (2013). “Conjunctivitis: a systematic review of diagnosis and treatment”. JAMA. 310 (16): 1721–9. doi:10.1001/jama.2013.280318. PMC 4049531. PMID 24150468.
  8. Centers for Disease Control and Prevention (2004) https://www.cdc.gov/mmwr/preview/mmwrhtml/mm5328a2.htm Accessed on June 24, 2016
  9. Workowski KA, Berman S, Centers for Disease Control and Prevention (CDC) (2010). “Sexually transmitted diseases treatment guidelines, 2010”. MMWR Recomm Rep. 59 (RR-12): 1–110. PMID 21160459.


Template:WikiDoc Sources

Classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [3]; Associate Editor(s)-in-Chief: Sara Mehrsefat, M.D. [4]

Overview

Conjunctivitis may be classified based on the duration of symptoms into hyperacute, acute, and chronic.[1][2] Additionally, conjunctivitis may be classified according to the causality of the inflammation or age groups into several subtypes: infective conjunctivitis (bacterial and viral), neonatal conjunctivitis (ophthalmia neonatorum), allergic conjunctivitis, keratoconjunctivitis sicca (dry eye syndrome), superior limbic keratoconjunctivitis, and chemical conjunctivitis.[3][4]

Classification

Based on the duration of symptoms, conjunctivitis may be classified into hyperacute, acute (less than 3 weeks), and chronic (greater than 3 weeks).

According to the etiology and age groups, conjunctivitis may be classified into:[5][6][5][7][8] [9]

References

  1. National Eye Institute (2015). [1] Accessed on June 23, 2016
  2. Blochmichel E, Helleboid L, Corvec MP (1993). “Chronic allergic conjunctivitis”. Ocul Immunol Inflamm. 1 (1–2): 9–12. doi:10.3109/09273949309086529. PMID 22827184.
  3. Alfonso SA, Fawley JD, Alexa Lu X (2015). “Conjunctivitis”. Prim Care. 42 (3): 325–45. doi:10.1016/j.pop.2015.05.001. PMID 26319341.
  4. Leonardi A, Castegnaro A, Valerio AL, Lazzarini D (2015). “Epidemiology of allergic conjunctivitis: clinical appearance and treatment patterns in a population-based study”. Curr Opin Allergy Clin Immunol. 15 (5): 482–8. doi:10.1097/ACI.0000000000000204. PMID 26258920.
  5. 5.0 5.1 Centers for Disease Control and Prevention (2016). [2] Accessed on June 23, 2016 Invalid parameter “viral” in <ref> tag. The supported parameters are: dir, follow, group, name.
  6. Menon BB, Zhou X, Spurr-Michaud S, Rajaiya J, Chodosh J, Gipson IK (2016). “Epidemic Keratoconjunctivitis-Causing Adenoviruses Induce MUC16 Ectodomain Release To Infect Ocular Surface Epithelial Cells”. mSphere. 1 (1). doi:10.1128/mSphere.00112-15. PMC 4863608. PMID 27303700.
  7. Mallika P, Asok T, Faisal H, Aziz S, Tan A, Intan G (2008). “Neonatal conjunctivitis – a review”. Malays Fam Physician. 3 (2): 77–81. PMC 4170304. PMID 25606121.
  8. Li Z, Chen W, Zhang Y, Jhanji V, Fan Z, Mu G (2015). “Topical Fluorometholone Versus Diclofenac Sodium in Cases With Perennial Allergic Conjunctivitis”. Eye Contact Lens. 41 (5): 310–3. doi:10.1097/ICL.0000000000000127. PMID 26322818.
  9. Bischoff G (2014). “[Giant papillary conjunctivitis]”. Klin Monbl Augenheilkd. 231 (5): 518–21. doi:10.1055/s-0034-1368334. PMID 24799171.

Template:WS Template:WH

Pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [3]; Associate Editor(s)-in-Chief: Sara Mehrsefat, M.D. [4]

Overview

Conjunctivitis is defined as inflammation of bulbar and/or palpebral conjunctiva. Conjunctivitis has many etiologies, but the majority of cases can be caused by allergies or infection. Infective conjunctivitis is an infection of the conjunctiva either caused by viruses or bacteria. Airborne antigens may be involved in the pathogenesis of allergic conjunctivitis. Common airborne antigens include pollen, grass, and weeds. Keratoconjunctivitis sicca (dry eye syndrome) is a multifactorial disease and associated with different medical conditions.[1][2]

Pathophysiology

Pathogenesis

Infective Conjunctivitis

Infective conjunctivitis is an infection of the conjunctiva either caused by viruses or bacteria, such as adenovirus, Staphylococcus aureus, Streptococcus pneumoniae, and Haemophilus influenzae. Any change in the host defense, or in the species of normal flora of the eye, can lead to clinical infection and conjunctivitis.

Change in the normal flora may occur by:[3]

Infective conjunctivitis is usually spread by:[1][2]

  • Direct contact with the infected person’s eye drainage or drainage from the person’s cough, sneeze, or runny nose
  • Contact with the infected person’s fingers, hands, or objects (eye makeup applicators, towels, shared eye medications)
  • Adjacent infectious sites (rubbing of the eyes)

Neonatal Conjunctivitis

Neonatal conjunctivitis is occurring in a newborn during the first month of life, and often known as ophthalmia neonatorum. Neonatal conjunctivitis is mainly caused by sexually transmitted diseases agents such as Chlamydia trachomatis, Neisseria gonorrhoeae, and herpes simplex virus (HSV). Chlamydia trachomatis is the most common cause of ophthalmia neonatorum in the developed countries because of higher prevalence of chlamydia as a sexually transmitted disease.

The recognized routes of transmission of the organisms to the newborns include:[4]

  • Infected birth canal during vaginal birth
  • Transmembrane transmission of the infection
  • Transplacental transmission of the infection

Additionally, silver nitrate drops (ocular prophylaxis) can cause ocular irritation and result in chemical conjunctivitis in newborn.[5]

Allergic Conjunctivitis

Development of allergic conjunctivitis is the result of type 1 hypersensitivity reaction in the conjunctiva. Allergic conjunctivitis is caused by the immunoglobulin E (IgE) mediated reaction to environmental allergens. Following exposure to environmental allergens in sensitized individual, the cross-linking of IgE at the mast cell membrane level results in subsequent cell degranulation and secretion of histamine, leukotriene, and prostaglandin. The principal effects of these products are vasodilation and smooth-muscle contraction. Common airborne antigens involve in the pathogenesis of allergic conjunctivitis include pollen, grass, and weeds.[6][7]

Combination of type 1 and type 4 hypersensitivity reactions may be responsible for giant papillary conjunctivitis. Also, prolonged mechanical irritation to the superior tarsal conjunctiva of the upper lid from foreign bodies may also be a contributing factor in giant papillary conjunctivitis.[8][9]

Keratoconjunctivitis Sicca

Keratoconjunctivitis sicca (dry eye syndrome) is a multifactorial disease and associated with different medical conditions such as:[10][11]

The exact pathogenesis of the keratoconjunctivitis sicca associated Sjögren’s syndrome is not fully understood. It is thought that keratoconjunctivitis sicca associated Sjögren’s syndrome is the result of lymphocytic infiltration and malfunction of the lacrimal glands. This lymphasitic infiltration (CD4+ T cells and B cells) may result in lacrimal gland dysfunction and reduced tear production (mediated by apoptosis).

Superior Limbic Keratoconjunctivitis

Superior limbic keratoconjunctivitis (SLK) is disease characterized by inflammation of the upper palpebral and superior bulbar conjunctiva. The exact pathogenesis of superior limbic keratoconjunctivitis is not fully understood, a mechanical hypothesis seems most attractive. It is thought that mechanical trauma from tight upper lids or loose redundant conjunctiva can lead to the disruption of normal epithelium. Also, the association between thyroid abnormalities (graves ophthalmopathy) and superior limbic keratoconjunctivitis has been reported.[12][13][14]

Gross Pathology

On gross pathology, the following are characteristic findings of conjunctivitis:[15]

Microscopic Histopathological Analysis

On microscopic histopathological analysis, the following are characteristic findings of conjunctivitis:[16]

Images

The following are gross and microscopic images associated with conjunctivitis:

References

  1. 1.0 1.1 Azari AA, Barney NP (2013). “Conjunctivitis: a systematic review of diagnosis and treatment”. JAMA. 310 (16): 1721–9. doi:10.1001/jama.2013.280318. PMC 4049531. PMID 24150468.
  2. 2.0 2.1 Kyei S, Koffuor GA, Ramkissoon P, Abokyi S, Owusu-Afriyie O, Wiredu EA (2015). “Possible Mechanism of Action of the Antiallergic Effect of an Aqueous Extract of Heliotropium indicum L. in Ovalbumin-Induced Allergic Conjunctivitis”. J Allergy (Cairo). 2015: 245370. doi:10.1155/2015/245370. PMC 4657065. PMID 26681960.
  3. Everitt H, Kumar S, Little P (2003). “A qualitative study of patients’ perceptions of acute infective conjunctivitis”. Br J Gen Pract. 53 (486): 36–41. PMC 1314490. PMID 12564275.
  4. Treadwell P (1994). “Sexually transmitted diseases in neonates and infants”. Semin Dermatol. 13 (4): 256–61. PMID 7848819.
  5. Mallika P, Asok T, Faisal H, Aziz S, Tan A, Intan G (2008). “Neonatal conjunctivitis – a review”. Malays Fam Physician. 3 (2): 77–81. PMC 4170304. PMID 25606121.
  6. Malling HJ, Montagut A, Melac M, Patriarca G, Panzner P, Seberova E; et al. (2009). “Efficacy and safety of 5-grass pollen sublingual immunotherapy tablets in patients with different clinical profiles of allergic rhinoconjunctivitis”. Clin Exp Allergy. 39 (3): 387–93. doi:10.1111/j.1365-2222.2008.03152.x. PMC 4233960. PMID 19134019.
  7. Kämpe M, Stålenheim G, Janson C, Stolt I, Carlson M (2007). “Systemic and local eosinophil inflammation during the birch pollen season in allergic patients with predominant rhinitis or asthma”. Clin Mol Allergy. 5: 4. doi:10.1186/1476-7961-5-4. PMC 2174506. PMID 17967188.
  8. Donshik PC (1994). “Giant papillary conjunctivitis”. Trans Am Ophthalmol Soc. 92: 687–744. PMC 1298525. PMID 7886881.
  9. Donshik PC, Porazinski AD (1999). “Giant papillary conjunctivitis in frequent-replacement contact lens wearers: a retrospective study”. Trans Am Ophthalmol Soc. 97: 205–16, discussion 216-20. PMC 1298261. PMID 10703125.
  10. Sivaraman KR, Jivrajka RV, Soin K, Bouchard CS, Movahedan A, Shorter E; et al. (2016). “Superior Limbic Keratoconjunctivitis-like Inflammation in Patients with Chronic Graft-Versus-Host Disease”. Ocul Surf. doi:10.1016/j.jtos.2016.04.003. PMID 27179980.
  11. Messmer EM (2015). “The pathophysiology, diagnosis, and treatment of dry eye disease”. Dtsch Arztebl Int. 112 (5): 71–81, quiz 82. doi:10.3238/arztebl.2015.0071. PMC 4335585. PMID 25686388.
  12. Nelson JD (1989). “Superior limbic keratoconjunctivitis (SLK)”. Eye (Lond). 3 ( Pt 2): 180–9. doi:10.1038/eye.1989.26. PMID 2695351.
  13. Chelala E, El Rami H, Dirani A, Fakhoury H, Fadlallah A (2015). “Extensive superior limbic keratoconjunctivitis in Graves’ disease: case report and mini-review of the literature”. Clin Ophthalmol. 9: 467–8. doi:10.2147/OPTH.S79561. PMC 4362972. PMID 25792798.
  14. American Academy of Ophthalmology (2015) http://eyewiki.aao.org/Superior_limbic_keratoconjunctivitis Accessed on June 27, 2016
  15. National Eye Institute (2015) [1] Accessed on June 24, 2016
  16. DermNet NZ (2015)[2] Accessed on June 26, 2016

Template:WS Template:WH

Causes

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [4]; Associate Editor(s)-in-Chief: Ogheneochuko Ajari, MB.BS, MS [5], Sara Mehrsefat, M.D. [6]

Overview

Common causes of conjunctivitis include bacteria, viruses, and environmental factors.[1] Viral conjunctivitis is the most common cause of infectious conjunctivitis both overall and in the adult population. Bacterial conjunctivitis is the second most common cause and is responsible for the majority of cases in children. Allergic conjunctivitis is the most frequent cause, affecting 15% to 40% of the population. Noninfectious conjunctivitis includes keratoconjunctivitis sicca (dry eye syndrome) and superior limbic keratoconjunctivitis may cause by inflammation secondary to immune-mediated diseases or mechanical irritation.[2]

Causes

Viral conjunctivitis[3]

Bacterial conjunctivitis[4]

Neonatal conjunctivitis[5][6]

Allergic conjunctivitis[3]

Keratoconjunctivitis[7]

Irritative Conjunctivitis


Causes by Organ System

Cardiovascular Kawasaki disease, plasminogen deficiency
Chemical / poisoning Acetaldehyde, acetic acid, acetic anhydride, acetylcarbromal, ammonia, anisole, arsenic trioxide, arsenic, arsenicals, beryllium, boric acid, box jellyfish poisoning, calcium sulfate, caterpillar poisoning, chemical irritation, chlorine dioxide, chloroacetophenone, cobra poisoning, CS gas, diethylene glycol monobutyl ether, dimethylamine, ether, ethylene oxide, euphorbiaceae, green lynx spider poisoning, hydrogen sulfide, lewisite, mayapple poisoning, metaldehyde, methylene diisocyanate, osmium, phosgene oxime, propylene glycol dinitrate, sulfuric acid, sulfuryl fluoride, toluene diisocyanate, vanadium, xylene
Dermatologic Acute febrile neutrophilic dermatosis, Behcet’s disease, cicatricial pemphigoid, dyskeratosis congenita, erythema multiformae, euphorbiaceae, Kawasaki disease, Kindler syndrome, lepidopterism, leprosy, ocular cicatricial pemphigoid, psoriatic arthritis, rosacea, Stevens-Johnson syndrome, Sweet’s syndrome, xeroderma pigmentosum
Drug Side Effect Acetylcarbromal, apraclonidine, artemether and lumefantrin, brimonidine tartrate and timolol maleate, cetuximab, clomethiazole, cyclopentolate, cytarabine, cytosine arabinose syndrome , desmopressin, dexamethasone, dimercaprol, dipivefrin, dornase alfa, doxorubicin hydrochloride, epirubicin hydrochloride, erythromycin, etretinate, flurbiprofen, fluticasone (spray), fosaprepitant, furfural, gadopentetate, galsulfase, hydroquinone, latanoprost,meclofenamate, medrysone,melarsoprol, methocarbamol, metipranolol, morpholine, moxifloxacin ophthalmic, nitisinone, orache (atriplex), pemetrexed, penicillium, pentamidine isethionate, pyridoxine hydrochloride, quinone, rasagiline, rifampin, rifapentin, secukinumab, sertraline, silver nitrate drops, tetracycline, thallous chloride tl 201, tocilizumab, travoprost
Ear Nose Throat Cogan syndrome, oral allergy syndrome
Endocrine No underlying causes
Environmental Aesculus pollen, alder, dust mite, environmental pollution,smog, smoke
Gastroenterologic No underlying causes
Genetic Crouzon syndrome, dyskeratosis congenita, familial cold urticaria, Job syndrome, Kindler syndrome, type II tyrosinemia, xeroderma pigmentosum, x-linked agammaglobulinaemia
Hematologic Hemorrhage, plasminogen deficiency, x-linked agammaglobulinaemia
Iatrogenic No underlying causes
Infectious Disease Acanthamoeba, adenovirus, alternaria, aspergillus, aureobasidium, candida albicans, cat scratch disease, chikungunya fever, chlamydia, cladosporium, congenital chlamydia, congenital gonorrhea, coxsackie virus, Crimean-Congo hemorrhagic fever, enterovirus 70, epicoccum, fusarium, gonorrhea, haemophilus influenzae, hantavirus pulmonary syndrome, helminth infections, helminthosporium, herpes simplex, herpes virus 2, herpes zoster, human enterovirus A, Kikuchi disease, Koch-Weeks conjunctivitis, leprosy, leptospirosis, listeria monocytogenes, Lyme disease, measles, molluscum contagiosum, moraxella catarrhalis, mucor, neisseria gonorrhoeae, neisseria meningiditis, Newcastle disease, non-specific urethritis, omsk hemorrhagic fever, onchocerciasis, pasteurella multocida, pediculosis ciliaris, pfiesteria piscicida, picornavirus, pseudomonas aeruginosa, psittacosis, respiratory syncytial virus, rhizopus, rosacea, rubella, sabia virus, serratia, smut, staphylococcus aureus, streptococcus pneumoniae, the clap, toxic-shock syndrome, trachoma, tularemia, viral conjunctivitis
Musculoskeletal / Ortho Burns, Crouzon Syndrome , polychondritis
Neurologic 7th cranial nerve disorder, facial nerve palsy
Nutritional / Metabolic Type II tyrosinemia, pyridoxine deficiency
Obstetric/Gynecologic No underlying causes
Oncologic Conjunctival squamous cell carcinoma, gestational trophoblastic neoplasia
Opthalmologic Allergic conjunctivitis, Angelucci’s syndrome, bacterial conjunctivitis, blepharitis, Cogan syndrome, conjunctival squamous cell carcinoma, contact lens, corneal abrasion, dacryocystitis, ectropion, entropion, epidemic keratoconjunctivitis, familial cold urticaria, follicular conjunctivitis, giant papillary conjunctivitis, keratoconjunctivitis sicca, lacrimal canaliculitis, ligneous conjunctivitis, ocular cicatricial pemphigoid, ocular rosacea, ophthalmia neonatorum, phlyctenular keratoconjunctivitis, Theodore’s superior limbic keratoconjunctivitis, trachoma, vernal conjunctivitis, vernal keratoconjunctivitis, viral conjunctivitis
Overdose / Toxicity No underlying causes
Psychiatric No underlying causes
Pulmonary Granulomatosis with polyangiitis, hantavirus pulmonary syndrome, Wegener’s granulomatosis
Renal / Electrolyte Wegener’s granulomatosis
Rheum / Immune / Allergy Allergic conjunctivitis, allergy, Behcet disease, cicatricial pemphigoid, common variable immunodeficiency, familial cold urticaria, familial hibernian fever, granulomatosis with polyangiitis, hay fever, hypersensitivity to pollen, Job syndrome, mold allergy, ocular cicatricial pemphigoid, oral allergy syndrome, polychondritis, psoriatic arthritis, reactive arthritis, Reiter’s syndrome, relapsing polychondritis, severe combined immunodeficiency, sicca syndrome, Sjogren’s syndrome, TNF receptor associated periodic syndrome, Wegener’s granulomatosis, x-linked agammaglobulinaemia
Sexual No underlying causes
Trauma Blunt injury, burns, penetrating trauma, trauma
Urologic Non-specific urethritis
Dental Crouzon syndrome
Miscellaneous American feverfew, ash juniper tree, ash tree, beech tree, bermuda grass, birch tree, box elder tree, canary grass, capeweed, cocklebur, cypress tree, daisy, dandelion, elm tree, foreign body, goosefoot, guayule, hemp, hickory tree, hornbeam tree, horse chestnut tree, johnson grass, kentucky bluegrass, maple tree, marshelder, monteroy pine tree, mountain cedar tree, mugwort tree, oak tree, olea tree, olive tree, orchard grass, pecan trees, pigweed, plane tree, pollen, poplar tree, ragweed, rapeseed oil, redtop grass, ryegrass, sunflower, tilia tree, timothy grass, tumble weed, velvet grass, wall pellitory, walnut tree, white cedar tree, willow tree

Causes in Alphabetical Order

References

  1. National Eye Institute (2015). [1] Accessed on June 23, 2016
  2. Azari AA, Barney NP (2013). “Conjunctivitis: a systematic review of diagnosis and treatment”. JAMA. 310 (16): 1721–9. doi:10.1001/jama.2013.280318. PMC 4049531. PMID 24150468.
  3. 3.0 3.1 Centers for Disease Control and Prevention (2016). [2] Accessed on June 23, 2016 Invalid parameter “viral” in <ref> tag. The supported parameters are: dir, follow, group, name.
  4. name= Bacterial Conjunctivitis > Centers for Disease Control and Prevention (2015). [3] Accessed on June 23, 2016
  5. Mallika P, Asok T, Faisal H, Aziz S, Tan A, Intan G (2008). “Neonatal conjunctivitis – a review”. Malays Fam Physician. 3 (2): 77–81. PMC 4170304. PMID 25606121.
  6. Woods, Charles R. “Gonococcal infections in neonates and young children.” Seminars in pediatric infectious diseases. Vol. 16. No. 4. WB Saunders, 2005.
  7. Barabino S, Dana MR (2007). “Dry eye syndromes”. Chem Immunol Allergy. 92: 176–84. doi:10.1159/000099268. PMID 17264493.

Template:WH Template:WS

Differentiating Conjunctivitis from other Diseases

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Mehrsefat, M.D. [2]

Overview

Conjunctivitis must be differentiated from blepharitis, keratitis, and scleritis.[1][2] Conjunctivitis symptoms and signs are relatively non-specific. Even after eye examination, laboratory tests are often necessary to determine the underlying pathophysiology with certainty.

Differentiating Conjunctivitis from Other Diseases

Bacterial Conjunctivitis

A mucopurulent discharge strongly suggests bacterial cause, unless there is known exposure to toxins. Infection with Neisseria gonorrhoeae and Chlamydia trachomatis should be suspected if the discharge is particularly thick and copious. Bacterial conjunctivitis must be differentiated from:[1][2]

Viral Conjunctivitis

A diffuse, highly contagious, characterized by watery discharge, less injected conjunctivitis (looking pink rather than red) suggests a viral cause. Viral conjunctivitis must be differentiated from:[3]

Neonatal conjunctivitis

Neonatal conjunctivitis must be differentiated from:[4][5]

  • Dacrocysitis
  • Congenital glaucoma
  • Nasolacrimal duct obstruction
  • Preseptal/Orbital cellulitis
  • Keratitis

Allergic conjunctivitis

Allergic conjunctivitis has a protracted course, with the severity of symptoms waxing and waning throughout the allergy season. It is characterized by itchy eyes, tearing, bilateral eye redness, and watery discharge. Allergic conjunctivitis must be differentiated from:[6]

  • Viral conjunctivitis
  • Bacterial conjunctivitis

Keratoconjunctivitis sicca

Keratoconjunctivitis sicca (dry eye syndrome) must be differentiated from:[7][8]

Superior limbic keratoconjunctivitis

Superior limbic keratoconjunctivitis (SLK) is chronic condition with remission and exacerbations, and it must be differentiated from:[9]

References

  1. 1.0 1.1 Leibowitz HM (2000). “The red eye”. N Engl J Med. 343 (5): 345–51. doi:10.1056/NEJM200008033430507. PMID 10922425.
  2. 2.0 2.1 American Academy of ophthalmology (2016) http://eyewiki.aao.org/Bacterial_Conjunctivitis Accessed on June 27, 2016
  3. Rose P (2007). “Management strategies for acute infective conjunctivitis in primary care: a systematic review”. Expert Opin Pharmacother. 8 (12): 1903–21. doi:10.1517/14656566.8.12.1903. PMID 17696792.
  4. Mallika P, Asok T, Faisal H, Aziz S, Tan A, Intan G (2008). “Neonatal conjunctivitis – a review”. Malays Fam Physician. 3 (2): 77–81. PMC 4170304. PMID 25606121.
  5. Woods, Charles R. “Gonococcal infections in neonates and young children.” Seminars in pediatric infectious diseases. Vol. 16. No. 4. WB Saunders, 2005.
  6. La Rosa M, Lionetti E, Reibaldi M, Russo A, Longo A, Leonardi S; et al. (2013). “Allergic conjunctivitis: a comprehensive review of the literature”. Ital J Pediatr. 39: 18. doi:10.1186/1824-7288-39-18. PMC 3640929. PMID 23497516.
  7. Zhang X, Zhao L, Deng S, Sun X, Wang N (2016). “Dry Eye Syndrome in Patients with Diabetes Mellitus: Prevalence, Etiology, and Clinical Characteristics”. J Ophthalmol. 2016: 8201053. doi:10.1155/2016/8201053. PMC 4861815. PMID 27213053.
  8. Sivaraman KR, Jivrajka RV, Soin K, Bouchard CS, Movahedan A, Shorter E; et al. (2016). “Superior Limbic Keratoconjunctivitis-like Inflammation in Patients with Chronic Graft-Versus-Host Disease”. Ocul Surf. doi:10.1016/j.jtos.2016.04.003. PMID 27179980.
  9. Watson S, Tullo AB, Carley F (2002). “Treatment of superior limbic keratoconjunctivitis with a unilateral bandage contact lens”. Br J Ophthalmol. 86 (4): 485–6. PMC 1771108. PMID 11914237.

] Template:WH Template:WS

Epidemiology and Demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Mehrsefat, M.D. [2]

Overview

Conjunctivitis accounts for 1% of all primary care and emergency room visits. The incidence of viral conjunctivitis is approximately 80,000 per 100,000 cases with acute conjunctivitis. Viral conjunctivitis more commonly affects adults while bacterial conjunctivitis more commonly affects children.

Epidemiology and Demographics

Prevalence and Incidence

  • The prevalence and incidence of conjunctivitis varies according to the underlying cause, which may be influenced by the patient’s age, as well as the season of the year.[1]

Infective Conjunctivitis

  • The incidence of viral conjunctivitis is approximately 80,000 per 100,000 cases with acute conjunctivitis.
  • The incidence of viral conjunctivitis caused by adenoviruses approximately ranges from 65,000 to 90,000 cases per 100,000 cases with viral conjunctivitis .
  • The incidence of viral conjunctivitis caused by herpes simplex virus (HSV) ranges from 1,300 to 4,800 cases per 100,000 cases with acute conjunctivitis.[2]
  • The incidence of bacterial conjunctivitis was estimated to be 1,350 cases per 100,000 cases with acute conjunctivitis.[3]

Neonatal Conjunctivitis

Allergic Conjunctivitis

Keratoconjunctivitis Sicca

Age

  • Viral conjunctivitis commonly affects adults, and bacterial conjunctivitis commonly affects children.
  • The incidence of infective conjunctivitis is higher in children <1 year old (8,000 cases per 100,000 patient) than in children >4 years of age (1,200 cases per 100,000 patient).[8]
  • Vernal keratoconjunctivitis (VKC), an allergic conjunctivitis subtype, commonly affects young males.[9]
  • Keraroconjunctivitis sicca commonly affects patients older than 40 years.[10]
  • Superior limbic keratoconjunctivitis (SLK) commonly affects middle-aged people (around the sixth decade of life).[11]

Gender

  • Infective Conjunctivitis occurs equally in males and females.[12]
  • The incidence of neonatal conjunctivitis does not vary by gender.[13]
  • Women are more commonly affected with keratoconjunctivitis sicca associated with Sjögren’s syndrome than men. The female to male ratio is approximately 9 to 1.[14]
  • Women are more commonly affected with Superior limbic keratoconjunctivitis (SLK) than men. The female to male ratio is approximately 3 to 1.[15]

Race

  • The prevalence of Infective conjunctivitis does not vary by race.[16]
  • Vernal keraroconjunctivitis commonly affects dark-skinned individuals from Africa and India.[17]
  • Keraroconjunctivitis sicca usually affects individuals of the Hispanic and Asian populations.[18]

Developed Countries

Prevalence of neonatal conjunctivitis has decreased significantly in developed countries since the abandonment of silver nitrate as topical prophylaxis. Current prevalence of neonatal conjunctivitis in developed countries are 5 per 1,000 live births.[19]

  • In Belgium and the Netherlands, the prevalence of neonatal conjunctivitis due to gonococcal infection was estimated 0.04 per 1,000 live births.[20]
  • In the United States, the prevalence of neonatal conjunctivitis due to gonococcal infection was estiamted 0.3 per 1,000 live births.
  • In the United States, the prevalence of neonatal conjunctivitis caused by chlamydial infection was estimated 5 to 60 cases per 1,000 live births.
  • In the United Kingdom, the prevalence of neonatal conjunctivitis caused by chlamydial infection was estimated 4 cases per 1,000 live births.[21]
  • In the United States, the incidence of bacterial conjunctivitis is 23,000 per 100,000 cases (in the 0-2 year age range), 28,000 per 100,000 cases (in the 3-9 year range), 13,000 per 100,000 cases (in the 10-19 year range) with the remaining 36,000 per 100,000 cases (in adults).[22]

Developing Countries

  • In developing countries, the incidence of bacterial conjunctivitis is continuing to decrease.
  • In the Africa, the incidence of neonatal conjunctivitis is still high.[21]

References

  1. Høvding G (2008). “Acute bacterial conjunctivitis”. Acta Ophthalmol. 86 (1): 5–17. doi:10.1111/j.1600-0420.2007.01006.x. PMID 17970823.
  2. Leibowitz HM (2000). “The red eye”. N Engl J Med. 343 (5): 345–51. doi:10.1056/NEJM200008033430507. PMID 10922425.
  3. Smith AF, Waycaster C (2009). “Estimate of the direct and indirect annual cost of bacterial conjunctivitis in the United States”. BMC Ophthalmol. 9: 13. doi:10.1186/1471-2415-9-13. PMC 2791746. PMID 19939250.
  4. Isenberg SJ, Apt L, Wood M (1996). “The influence of perinatal infective factors on ophthalmia neonatorum”. J Pediatr Ophthalmol Strabismus. 33 (3): 185–8. PMID 8771523.
  5. Leonardi A, Castegnaro A, Valerio AL, Lazzarini D (2015). “Epidemiology of allergic conjunctivitis: clinical appearance and treatment patterns in a population-based study”. Curr Opin Allergy Clin Immunol. 15 (5): 482–8. doi:10.1097/ACI.0000000000000204. PMID 26258920.
  6. Rosario N, Bielory L (2011) Epidemiology of allergic conjunctivitis. Curr Opin Allergy Clin Immunol 11 (5):471-6. DOI:10.1097/ACI.0b013e32834a9676 PMID: 21785348
  7. Schaumberg DA, Sullivan DA, Buring JE, Dana MR (2003). “Prevalence of dry eye syndrome among US women”. Am J Ophthalmol. 136 (2): 318–26. PMID 12888056.
  8. Rose P (2007). “Management strategies for acute infective conjunctivitis in primary care: a systematic review”. Expert Opin Pharmacother. 8 (12): 1903–21. doi:10.1517/14656566.8.12.1903. PMID 17696792. Unknown parameter |month= ignored (help)
  9. Bonini S, Coassin M, Aronni S, Lambiase A (2004). “Vernal keratoconjunctivitis”. Eye (Lond). 18 (4): 345–51. doi:10.1038/sj.eye.6700675. PMID 15069427.
  10. Schaumberg DA, Dana R, Buring JE, Sullivan DA (2009). “Prevalence of dry eye disease among US men: estimates from the Physicians’ Health Studies”. Arch Ophthalmol. 127 (6): 763–8. doi:10.1001/archophthalmol.2009.103. PMC 2836718. PMID 19506195.
  11. Watson S, Tullo AB, Carley F (2002). “Treatment of superior limbic keratoconjunctivitis with a unilateral bandage contact lens”. Br J Ophthalmol. 86 (4): 485–6. PMC 1771108. PMID 11914237.
  12. Fitch CP, Rapoza PA, Owens S, Murillo-Lopez F, Johnson RA, Quinn TC; et al. (1989). “Epidemiology and diagnosis of acute conjunctivitis at an inner-city hospital”. Ophthalmology. 96 (8): 1215–20. PMID 2797725.
  13. Moore DL, MacDonald NE, Canadian Paediatric Society, Infectious Diseases and Immunization Committee (2015). “Preventing ophthalmia neonatorum”. Can J Infect Dis Med Microbiol. 26 (3): 122–5. PMC 4507834. PMID 26236350.
  14. “The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye WorkShop (2007)”. Ocul Surf. 5 (2): 93–107. 2007. PMID 17508117.
  15. Nelson JD (1989). “Superior limbic keratoconjunctivitis (SLK)”. Eye (Lond). 3 ( Pt 2): 180–9. doi:10.1038/eye.1989.26. PMID 2695351.
  16. O’Brien TP, Jeng BH, McDonald M, Raizman MB (2009). “Acute conjunctivitis: truth and misconceptions”. Curr Med Res Opin. 25 (8): 1953–61. doi:10.1185/03007990903038269. PMID 19552618.
  17. Bremond-Gignac D, Donadieu J, Leonardi A, Pouliquen P, Doan S, Chiambarretta F; et al. (2008). “Prevalence of vernal keratoconjunctivitis: a rare disease?”. Br J Ophthalmol. 92 (8): 1097–102. doi:10.1136/bjo.2007.117812. PMID 18356259.
  18. Moss SE, Klein R, Klein BE (2000). “Prevalence of and risk factors for dry eye syndrome”. Arch Ophthalmol. 118 (9): 1264–8. PMID 10980773.
  19. Azari AA, Barney NP (2013). “Conjunctivitis: a systematic review of diagnosis and treatment”. JAMA. 310 (16): 1721–9. doi:10.1001/jama.2013.280318. PMC 4049531. PMID 24150468.
  20. Mallika P, Asok T, Faisal H, Aziz S, Tan A, Intan G (2008). “Neonatal conjunctivitis – a review”. Malays Fam Physician. 3 (2): 77–81. PMC 4170304. PMID 25606121.
  21. 21.0 21.1 Schaller UC, Klauss V (2001). “Is Credé’s prophylaxis for ophthalmia neonatorum still valid?”. Bull World Health Organ. 79 (3): 262–3. PMC 2566367. PMID 11285676.
  22. Epling J (2010). “Bacterial conjunctivitis”. BMJ Clin Evid. 2010. PMC 2907624. PMID 21718563.


Template:WikiDoc Sources

Risk Factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Mehrsefat, M.D. [2]

Overview

The most potent risk factor in the development of infective conjunctivitis is a direct or indirect contact with an infected person’s eye drainage. Common risk factors in the development of conjunctivitis are poor hygienic habits, contaminated personal articles, history of ocular diseases (dry eye, blepharitis, and anatomic abnormalities of the ocular surface), recent ocular surgery, medication use, and history of autoimmune disorders. Additionally, vaginal delivery is a risk factor for conjunctivitis in babies born to mothers infected with either Neisseria gonorrhoeae or Chlamydia trachomatis.[1][2]

Risk Factors

Infective Conjunctivitis

Common risk factors in the development of infective conjunctivitis include:[2][3][4]

  • Poor hygiene
  • Contact lens misuse
  • Contaminated personal articles
  • Crowded living or social conditions (elementary schools, military barracks)
  • History of ocular diseases including dry eye, blepharitis, and anatomic abnormalities of the ocular surface and lids
  • Recent ocular surgery, exposed sutures, or ocular foreign bodies
  • Chronic use of topical medications
  • Immune compromise
  • Winter/Summer months (bacterial conjunctivitis peaks in the winter and viral conjunctivitis peaks in the summer)

Neonatal Conjunctivitis

Common risk factors in the development of neonatal conjunctivitis include:[5][6][7]

Allergic Conjunctivitis

Common risk factors in the development of allergic conjunctivitis include:[8][9]

  • Pollen from trees and grass
  • Animal skin and secretions, such as saliva
  • Perfumes
  • Cosmetics
  • Air pollution
  • Smoke
  • Spring/Summer months

Keratoconjunctivitis Sicca

Common risk factors in the development of keratoconjunctivitis sicca (dry eye syndrome) include:[10][11][12]

Superior Limbic Keratoconjunctivitis

Common risk factors in the development of superior limbic keratoconjunctivitis (SLK) include:[13][14]

  • Mechanical soft-tissue microtrauma (conjunctiva laxity)
  • Morphologic changes in superior conjunctival
  • Prolonged eyelid closure
  • Thyroid abnormalities

References

  1. Epling J (2010). “Bacterial conjunctivitis”. BMJ Clin Evid. 2010. PMC 2907624. PMID 21718563.
  2. 2.0 2.1 Cronau H, Kankanala RR, Mauger T (2010). “Diagnosis and management of red eye in primary care”. Am Fam Physician. 81 (2): 137–44. PMID 20082509.
  3. Gigliotti F, Williams WT, Hayden FG, Hendley JO, Benjamin J, Dickens M; et al. (1981). “Etiology of acute conjunctivitis in children”. J Pediatr. 98 (4): 531–6. PMID 6970802.
  4. Tagliaferri A, Love TE, Szczotka-Flynn LB (2014). “Risk factors for contact lens-induced papillary conjunctivitis associated with silicone hydrogel contact lens wear”. Eye Contact Lens. 40 (3): 117–22. doi:10.1097/ICL.0000000000000019. PMC 4113198. PMID 24681609.
  5. Gichuhi S, Bosire R, Mbori-Ngacha D, Gichuhi C, Wamalwa D, Maleche-Obimbo E; et al. (2009). “Risk factors for neonatal conjunctivitis in babies of HIV-1 infected mothers”. Ophthalmic Epidemiol. 16 (6): 337–45. doi:10.3109/09286580903144746. PMC 3223245. PMID 19995198.
  6. Zar HJ (2005). “Neonatal chlamydial infections: prevention and treatment”. Paediatr Drugs. 7 (2): 103–10. PMID 15871630.
  7. Nahmias AJ, Visintine AM, Caldwell DR, Wilson LA (1976). “Eye infections with herpes simplex viruses in neonates”. Surv Ophthalmol. 21 (2): 100–5. PMID 982267.
  8. Hsieh VC, Liu CC, Hsiao YC, Wu TN (2016). “Risk of Allergic Rhinitis, Allergic Conjunctivitis, and Eczema in Children Born to Mothers with Gum Inflammation during Pregnancy”. PLoS One. 11 (5): e0156185. doi:10.1371/journal.pone.0156185. PMC 4880316. PMID 27224053.
  9. Borish L (2003). “Allergic rhinitis: systemic inflammation and implications for management”. J Allergy Clin Immunol. 112 (6): 1021–31. doi:10.1016/j.jaci.2003.09.015. PMID 14657851.
  10. Gumus K, Cavanagh DH (2009). “The role of inflammation and antiinflammation therapies in keratoconjunctivitis sicca”. Clin Ophthalmol. 3: 57–67. PMC 2709015. PMID 19668545.
  11. Stern ME, Beuerman RW, Fox RI, Gao J, Mircheff AK, Pflugfelder SC (1998). “The pathology of dry eye: the interaction between the ocular surface and lacrimal glands”. Cornea. 17 (6): 584–9. PMID 9820935.
  12. Zhang X, Zhao L, Deng S, Sun X, Wang N (2016). “Dry Eye Syndrome in Patients with Diabetes Mellitus: Prevalence, Etiology, and Clinical Characteristics”. J Ophthalmol. 2016: 8201053. doi:10.1155/2016/8201053. PMC 4861815. PMID 27213053.
  13. Nelson JD (1989). “Superior limbic keratoconjunctivitis (SLK)”. Eye (Lond). 3 ( Pt 2): 180–9. doi:10.1038/eye.1989.26. PMID 2695351.
  14. Chelala E, El Rami H, Dirani A, Fakhoury H, Fadlallah A (2015). “Extensive superior limbic keratoconjunctivitis in Graves’ disease: case report and mini-review of the literature”. Clin Ophthalmol. 9: 467–8. doi:10.2147/OPTH.S79561. PMC 4362972. PMID 25792798.


Template:WikiDoc Sources

Screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sara Mehrsefat, M.D. [2]

Overview

General screening for conjunctivitis is not recommended. However, according to the Centers for Disease Control and Prevention (CDC), screening for sexually transmitted diseases (STDs) is recommended among pregnant women to prevent conjunctivitis and other medical conditions in newborns.[1]

Screening

General screening for conjunctivitis is not recommended. However, if a baby is born to a mother who has an sexually transmitted disease (STD), during delivery the bacteria (Chlamydia trachomatis, Neisseria gonorrhoeae) or virus (Herpes simplex virus) can pass from the birth canal into the baby’s eyes, and cause septic conjunctivitis. Antibiotic ointment or eye drops is given to all babies immediately after birth to prevent conjunctivitis and other medical conditions in newborns. Occasionally, this treatment causes a mild chemical conjunctivitis, which is usually self-limiting. Screening has been recommended by CDC in pregnant women for sexually transmitted diseases (STDs) to prevent spreading the infection to the baby.[1][2]

Organism Screening Recommendations in Pregnant Women
Chlamydia
  • All pregnant women under 25 years of age
  • Pregnant women, aged 25 and older if at increased risk
  • Retest during the 3rd trimester for women under 25 years of age or at risk
  • Pregnant women with chlamydial infection should have a test-of-cure 3-4 weeks after treatment and be retested within 3 months
Gonorrhea
  • All pregnant women under 25 years of age and older women if at increased risk
  • Retest 3 months after treatment
Herpes simplex virus
  • Evidence does not support routine HSV-2 serologic screening among asymptomatic pregnant women. However, type-specific serologic tests might be useful for identifying pregnant women at risk for HSV infection and guiding counseling regarding the risk for acquiring genital herpes during pregnancy

References

  1. 1.0 1.1 Centers for Disease Control and Prevention (2015) http://www.cdc.gov/std/tg2015/screening-recommendations.htm Accessed on June 29, 2016
  2. Centers for Disease Control and Prevention (2002) http://www.cdc.gov/mmwr/PDF/rr/rr5115.pdf Accessed on June 29, 2016

Template:WS Template:WH

Natural History, Complications and Prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [2]; Associate Editor(s)-in-Chief: Sara Mehrsefat, M.D. [3]

Overview

If left untreated, viral conjunctivitis will generally clear without any complications. Bacterial conjunctivitis is often self-limited. If left untreated, bacterial conjunctivitis will clear within 1 or 2 weeks without any complications, and it is generally associated with a favorable long-term prognosis.[1] Allergic conjunctivitis improves by eliminating or significantly reducing contact with the allergen. If left untreated, most cases of allergic conjunctivitis may resolve without any long-term consequences. Keratoconjunctivitis sicca associated with Sjögren’s syndrome is associated with a particularly poor prognosis and requiring a longer course of treatment.[2][3][4] Prognosis for conjunctivitis is generally good with treatment.

Natural History

Viral conjunctivitis is often caused by adenovirus. It presents with watery discharge, hyperemia, chemosis, and lymphadenopathy. If left untreated, most cases of viral conjunctivitis are mild and will clear in 7 to 14 days without any long-term consequences. if complications arise, viral conjunctivitis can take two or more weeks to resolve. Some cases of viral conjunctivitis may develop stromal or subepithelial abnormalities. In such cases, if subepithelial infiltrates are in the pupillary axis, they may lead to decreased vision. Usually stromal abnormalities may persist for months to years, long after the epithelial changes have resolved.[1][2][5]

Acute hemorrhagic conjunctivitis is often caused by picornavirus. It presents with a severe red, swollen eyes as well as subconjuntival hemorrhaging, and will clear up in 5 to 7 days. If left untreated, acute hemorrhagic conjunctivitis almost always resolves without sequelae.[6]

Bacterial conjunctivitis presents with red eye, mucopurulent discharge, and chemosis. The incubation period for bacterial conjunctivitis is estimated to be 1 to 7 days. If left untreated, most cases of bacterial conjunctivitis will clear in 7 to 10 days without any long-term consequences. If left untreated, In patients who have purulent or mucopurulent discharge (suspected chlamydial and gonococcal conjunctivitis), who wear contact lenses, and who are immunocompromised, conjunctivitis may cause corneal damage (such as corneal ulcer, scar, and perforation), sepsis, and meningitis. This may lead to permanent blindness and death.[1][2][7]

Hyperacute bacterial conjunctivitis (HBC) is often caused by Neisseria gonorrhoeae in sexually active adults. It presents with a severe copious purulent discharge, eyelid swelling, eye pain on palpation, preauricular adenopathy, and decreased vision. If left untreated, hyperacute bacterial conjunctivitis may cause corneal involvement, and ultimately corneal perforation.[8]

Neonatal conjunctivitis is one of the most common infections occurring in the first month of life. Chemical conjunctivitis secondary to silver nitrate solution application usually occurs in the first day of life, and disappears spontaneously within 2- 4 days. In the absence of adequate prophylaxis, 30% to 42% of infants born by vaginal delivery to infected mothers will develop gonococcal conjunctivitis. Gonococcal conjunctivitis tends to occur 2-7 days after birth, and tends to be more severe than other causes of ophthalmia neonatorum. It presents with severe bilateral purulent conjunctivitis, tearing, and eyelids swelling. If left untreated, gonococcal conjunctivitis may cause corneal involvement such as corneal ulceration, diffuse opacification, and corneal perforation. This may lead to blindness, sepsis, or death. The onset of chlamydial conjunctivitis is usually later than gonococcal conjunctivitis. In the absence of adequate prophylaxis, 30%-50% of infants born by vaginal delivery to infected mothers will develop chlamydial conjunctivitis. The incubation period is 5-14 days. Chlamydial conjunctivitis presents with mild hyperemia, watery discharge, eyelid swelling, papillary reaction, and pseudomembrane formation. If left untreated, chlamydial conjunctivitis can progress to copious and purulent discharge. This may lead to central corneal opacification and blindness. Herpetic conjunctivitis is a rare cause of neonatal conjunctivitis. Herpetic conjunctivitis usually occurs within the first 2 weeks after birth and has an incubation period of approximately 6-14 days. If left untreated, HSV conjunctivitis can cause corneal scarring and ulceration. Additionally, disseminated HSV infection can cause central nervous system (CNS) involvement. Ophthalmia neonatorum caused by pseudomonas is rare but can present with eyelid edema, erythema, and purulent discharge. If left untreated, ophthalmia neonatorum can progress to corneal perforation, endophthalmitis, blindness, and possibly death.[9][10][11]

Allergic conjunctivitis usually presents with itching of the eyes and eyelid swelling. Seasonal allergic conjunctivitis is the most common form of the condition, and symptoms are related to season-specific aeroallergens. If left untreated, most cases of allergic conjunctivitis improve by eliminating or significantly reducing contact with the allergen (pollen or animal dander) without any long-term consequences.[12][13][14]

Keratoconjunctivitis sicca (dry eye syndrome) presents with a foreign body sensation, mucoid discharge, ocular dryness, excessive tearing (reflex secretion), photophobia, itching, and blurry vision. Symptoms tend to be worse toward the end of the day with prolonged use of the eyes. If left untreated, it can progress to corneal ulceration, corneal perforation, and ultimately permanent blindness.[3][15][16]

Superior limbic keratoconjunctivitis (SLK) symptoms develop around the sixth decade of life, and include a foreign body sensation, burning sensation, pruritus, and dry eye sensation. Superior limbic keratoconjunctivitis is typically associated with remission as the natural history and eventual total resolution, although symptoms may last for years.[4][17]

Complications

Viral Conjunctivitis

Complications to viral conjunctivitis include:[5][18]

  • Bacterial superinfection
  • Keratitis
  • Subepithelial infiltrates
  • Corneal ulceration with keratoconjunctivitis
  • Chronic infection

Bacterial Conjunctivitis

Complications to bacterial conjunctivitis include:[19][20]

Neonatal Conjunctivitis

Complications to neonatal conjunctivitis include:[11][21]

Allergic Conjunctivitis

Complications to allergic conjunctivitis include:[13][14]

  • Conjunctivochalasis (chronic recurrences)
  • Corneal ulceration
  • Corneal opacification
  • Visual loss
  • Steroid induced intraocular pressure elevations
  • Cataract

Keratoconjunctivitis Sicca

Complications to Keratoconjunctivitis sicca (dry eye syndrome) include:[15][16]

Prognosis

  • Viral conjunctivitis is often associated with a favorable long-term prognosis. However, viral conjunctivitis associated with subepithelial infiltrates may last for several months and cause decreased vision.[5][18]
  • Acute hemorrhagic conjunctivitis almost always resolves without sequelae, and has a good visual prognosis.[6]
  • Bacterial conjunctivitis is often associated with a favorable long-term prognosis.

Early detection and early treatment of extremely pathogenic bacteria, such as Chlamydia trachomatis or Neisseria gonorrhoeae, is associated with a good prognosis.[19][20]

References

  1. 1.0 1.1 1.2 Leibowitz HM (2000). “The red eye”. N Engl J Med. 343 (5): 345–51. doi:10.1056/NEJM200008033430507. PMID 10922425.
  2. 2.0 2.1 2.2 Rose P (2007). “Management strategies for acute infective conjunctivitis in primary care: a systematic review”. Expert Opin Pharmacother. 8 (12): 1903–21. doi:10.1517/14656566.8.12.1903. PMID 17696792.
  3. 3.0 3.1 Schaumberg DA, Dana R, Buring JE, Sullivan DA (2009). “Prevalence of dry eye disease among US men: estimates from the Physicians’ Health Studies”. Arch Ophthalmol. 127 (6): 763–8. doi:10.1001/archophthalmol.2009.103. PMC 2836718. PMID 19506195.
  4. 4.0 4.1 4.2 Watson S, Tullo AB, Carley F (2002). “Treatment of superior limbic keratoconjunctivitis with a unilateral bandage contact lens”. Br J Ophthalmol. 86 (4): 485–6. PMC 1771108. PMID 11914237.
  5. 5.0 5.1 5.2 Jhanji V, Chan TC, Li EY, Agarwal K, Vajpayee RB (2015). “Adenoviral keratoconjunctivitis”. Surv Ophthalmol. 60 (5): 435–43. doi:10.1016/j.survophthal.2015.04.001. PMID 26077630.
  6. 6.0 6.1 Yin-Murphy M (1976). “Simple tests for the diagnosis of picornavirus epidemic conjunctivitis (acute haemorrhagic conjunctivitis)”. Bull World Health Organ. 54 (6): 675–9. PMC 2366581. PMID 1088513.
  7. Azari AA, Barney NP (2013). “Conjunctivitis: a systematic review of diagnosis and treatment”. JAMA. 310 (16): 1721–9. doi:10.1001/jama.2013.280318. PMC 4049531. PMID 24150468.
  8. Høvding G (2008). “Acute bacterial conjunctivitis”. Acta Ophthalmol. 86 (1): 5–17. doi:10.1111/j.1600-0420.2007.01006.x. PMID 17970823.
  9. Mallika P, Asok T, Faisal H, Aziz S, Tan A, Intan G (2008). “Neonatal conjunctivitis – a review”. Malays Fam Physician. 3 (2): 77–81. PMC 4170304. PMID 25606121.
  10. Matejcek A, Goldman RD (2013). “Treatment and prevention of ophthalmia neonatorum”. Can Fam Physician. 59 (11): 1187–90. PMC 3828094. PMID 24235191.
  11. 11.0 11.1 11.2 Fransen L, Nsanze H, Klauss V, Van der Stuyft P, D’Costa L, Brunham RC; et al. (1986). “Ophthalmia neonatorum in Nairobi, Kenya: the roles of [[Neisseria gonorrhoeae]] and [[Chlamydia trachomatis]]. J Infect Dis. 153 (5): 862–9. PMID 3084664. URL–wikilink conflict (help)
  12. La Rosa M, Lionetti E, Reibaldi M, Russo A, Longo A, Leonardi S; et al. (2013). “Allergic conjunctivitis: a comprehensive review of the literature”. Ital J Pediatr. 39: 18. doi:10.1186/1824-7288-39-18. PMC 3640929. PMID 23497516.
  13. 13.0 13.1 Jun J, Bielory L, Raizman MB (2008). “Vernal conjunctivitis”. Immunol Allergy Clin North Am. 28 (1): 59–82, vi. doi:10.1016/j.iac.2007.12.007. PMID 18282546.
  14. 14.0 14.1 Bonini S (2004). “Atopic keratoconjunctivitis”. Allergy. 59 Suppl 78: 71–3. doi:10.1111/j.1398-9995.2004.00570.x. PMID 15245362.
  15. 15.0 15.1 Zoukhri D (2006). “Effect of inflammation on lacrimal gland function”. Exp Eye Res. 82 (5): 885–98. doi:10.1016/j.exer.2005.10.018. PMC 1361268. PMID 16309672.
  16. 16.0 16.1 16.2 Stern ME, Beuerman RW, Fox RI, Gao J, Mircheff AK, Pflugfelder SC (1998). “The pathology of dry eye: the interaction between the ocular surface and lacrimal glands”. Cornea. 17 (6): 584–9. PMID 9820935.
  17. 17.0 17.1 Nelson JD (1989). “Superior limbic keratoconjunctivitis (SLK)”. Eye (Lond). 3 ( Pt 2): 180–9. doi:10.1038/eye.1989.26. PMID 2695351.
  18. 18.0 18.1 Drug and Therapeutics Bulletin (2011). “Management of acute infective conjunctivitis”. Drug Ther Bull. 49 (7): 78–81. doi:10.1136/dtb.2011.02.0043. PMID 21733975.
  19. 19.0 19.1 Høvding G (2004). “[Acute bacterial conjunctivitis]”. Tidsskr Nor Laegeforen. 124 (11): 1518–20. PMID 15195156.
  20. 20.0 20.1 “Bacterial conjunctivitis in children: antibiotic eye drops only if eye washing is ineffective”. Prescrire Int. 16 (89): 120–1. 2007. PMID 17585426.
  21. 21.0 21.1 Centers for Disease Control and Prevention (2015)[1] Accessed on June 30, 2016
  22. Workowski KA, Berman S, Centers for Disease Control and Prevention (CDC) (2010). “Sexually transmitted diseases treatment guidelines, 2010”. MMWR Recomm Rep. 59 (RR-12): 1–110. PMID 21160459.
  23. Kumar S (2009). “Vernal keratoconjunctivitis: a major review”. Acta Ophthalmol. 87 (2): 133–47. doi:10.1111/j.1755-3768.2008.01347.x. PMID 18786127.


Template:WikiDoc Sources

Diagnosis

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | Chest X Ray | CT | MRI | Other Imaging Findings | Other Diagnostic Studies

Treatment

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy

Case Studies

Case Studies

Case #1


Template:WikiDoc Sources

Looking for the patient version?

Back to the patient-friendly article

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH